South America Molecular Biology Enzymes, Kits, and Reagents Market
No. of Pages: 163 | Report Code: TIPRE00025777 | Category: Life Sciences
No. of Pages: 163 | Report Code: TIPRE00025777 | Category: Life Sciences
SAM molecular biology enzymes, kits and reagents market is studied on the basis of the two major countries such as Brazil, Argentina and on the basis of rest of SAM. The recent technological developments have had a direct impact on the economy of Brazil that has advanced to a large extent. The advancement and higher rate of the development in the field of the biotechnology and the developments done by the local players in the region are likely to drive the market of the molecular biology enzymes, kits & reagents. The molecular biology enzymes, kits and reagents market in the region is likely to grow at a speedy rate and is anticipated to increase its market share in the global market during the forecast period.
SAM have been witnessing a growing number of COVID-19 cases since its outbreak. The cases are increasing in Brazil, Argentina, Colombia. The COVID-19 is expected to result in the region's worst recession, causing a 9.1% contraction in regional GDP in 2020. This is expected to increase the number of poor up by 45 million and the extremely poor number by 28 million. The increasing incidence supports the growth of the market. The pharmaceutical & biotechnology invested in R&D for the new molecule entity. The pandemic as no impact on R&D process, due to pandemic R&D activity increase to find better medicines to cure the life-threatening disease. These factors had a high impact on the SAM molecular biology enzymes, kits & reagents market.
Strategic insights for the South America Molecular Biology Enzymes, Kits, and Reagents provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 409.79 Million |
| Market Size by 2028 | US$ 1,167.37 Million |
| Global CAGR (2021 - 2028) | 16.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | South and Central America
|
| Market leaders and key company profiles |
The geographic scope of the South America Molecular Biology Enzymes, Kits, and Reagents refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The molecular biology enzymes, kits, and reagents market in SAM is expected to grow from US$ 409.79 million in 2021 to US$ 1,167.37 million by 2028; it is estimated to grow at a CAGR of 16.1% from 2021 to 2028. Some of the prominent countries contributing to the growth of the molecular biology enzymes, kits and reagents market include Colombia, Peru, and Bolivia. The market growth of molecular biology enzymes, kits and reagents is attributed to the rising infectious disease, increasing awareness of molecular diagnostics and adoption of sophisticated healthcare facilities and the biopharmaceutical industry. Non-communicable diseases (NCDs) are long-term, slowly progressing diseases that can create severe complications for those they impact. NCDs account for 63% of annual deaths in the world includes such diseases as cancer, diabetes, and cardiovascular disease, and impact low-to-middle-income countries.
Moreover, the expansion activities of diagnostic companies are also creating demand for enzymes, kits and reagents. Other factors include increasing number of life science and drug discovery research institutes with increasing number of research and development activities and increasing government initiatives to promote research in biotechnology institutions in the country. This causes huge demand for various molecular biology enzymes and reagents, which will further augment the growth of this market in the country.
SAM molecular biology enzymes, kits, and reagents market is segmented into product, application, end user, and country. Based on product, the molecular biology enzymes, kits, and reagents market is bifurcated into enzymes and kits & reagents. The market, by enzymes, is further segmented into polymerases, ligases, reverse transcriptases, phosphatases, proteases and proteinases, restriction endonuclease, and other. The kits & reagent segment held a larger market share in 2020. The molecular biology enzymes, kits, and reagents market, based on application, is segmented into epigenetics, sequencing, synthetic biology, polymerase chain reaction, and other. In 2020, the sequencing segment held the largest market share. In terms of end user, the molecular biology enzymes, kits, and reagents market is segmented into biotechnological and pharmaceutical companies, hospitals and diagnostic centers, and academic and research institutes. The biotechnological and pharmaceutical companies segment held the largest share of the market in 2020. Based on country, the SAM molecular biology enzymes, kits, and reagents market is segmented into Brazil, Argentina, and rest of SAM. Brazil held the largest market share in 2020.
A few major primary and secondary sources referred to for preparing this report on the molecular biology enzymes, kits, and reagents market in SAM are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Agilent Technologies, Inc.; F. HOFFMANN-LA ROCHE LTD; Illumina, Inc.; Merck KGAA; MERIDIAN BIOSCIENCE, INC; Promega Corporation; Qiagen; and THERMO FISHER SCIENTIFIC INC.
The South America Molecular Biology Enzymes, Kits, and Reagents Market is valued at US$ 409.79 Million in 2021, it is projected to reach US$ 1,167.37 Million by 2028.
As per our report South America Molecular Biology Enzymes, Kits, and Reagents Market, the market size is valued at US$ 409.79 Million in 2021, projecting it to reach US$ 1,167.37 Million by 2028. This translates to a CAGR of approximately 16.1% during the forecast period.
The South America Molecular Biology Enzymes, Kits, and Reagents Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Molecular Biology Enzymes, Kits, and Reagents Market report:
The South America Molecular Biology Enzymes, Kits, and Reagents Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South America Molecular Biology Enzymes, Kits, and Reagents Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South America Molecular Biology Enzymes, Kits, and Reagents Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South America Molecular Biology Enzymes, Kits, and Reagents Market
